Upon human infection via mosquito bite, CHIKV enters the bloodstream, where its envelope glycoproteins engage the human host receptor MXRA8 (also known as DICAM, ASP3, or Limitrin) to mediate viral entry. Here, MXRA8 is linked to infection.